Takeda Pharmaceutical Company Limited Share Price Wiener Boerse
Equities
TKD
JP3463000004
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.33 EUR | -0.94% | -1.06% | -5.77% |
16/05 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
15/05 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
Sales 2024 | 4,264B 27.2B 25.11B 2,265B | Sales 2025 * | 4,097B 26.13B 24.13B 2,176B | Capitalization | 6,436B 41.05B 37.91B 3,418B |
---|---|---|---|---|---|
Net income 2024 | 144B 919M 849M 76.52B | Net income 2025 * | 136B 866M 799M 72.08B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.05B 22.21B 2,003B | Net Debt 2025 * | 4,204B 26.82B 24.76B 2,233B | EV / Sales 2025 * | 2.6 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
45.5
x | Employees | 49,095 |
Yield 2024 * |
4.58% | Yield 2025 * |
4.65% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | -0.94% | ||
1 week | -1.06% | ||
Current month | -1.30% | ||
1 month | -3.53% | ||
3 months | -11.20% | ||
6 months | -5.15% | ||
Current year | -5.77% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 01/14/01 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/22/01 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 01/12/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 01/16/01 | |
Ian Clark
BRD | Director/Board Member | 62 | 01/19/01 |
Steven Gillis
BRD | Director/Board Member | 71 | 01/19/01 |
Date | Price | Change |
---|---|---|
22/24/22 | 24.18 | -0.62% |
21/24/21 | 24.33 | -0.94% |
20/24/20 | 24.56 | +1.03% |
17/24/17 | 24.31 | -0.61% |
16/24/16 | 24.46 | -0.53% |
End-of-day quote Wiener Boerse, May 21, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.74% | 723B | |
+32.22% | 598B | |
-2.07% | 364B | |
+20.25% | 331B | |
+2.99% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+7.43% | 169B |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock